{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:20:14Z","timestamp":1767144014227,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/j.atherosclerosis.2009.08.003","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"record-id":"1017"}],"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.atherosclerosis.2009.08.003","type":"journal-article","created":{"date-parts":[[2009,8,9]],"date-time":"2009-08-09T04:09:57Z","timestamp":1249790997000},"page":"211-214","source":"Crossref","is-referenced-by-count":10,"title":["RETRACTED: A role for plasma transforming growth factor-\u03b2 and matrix metalloproteinases in aortic aneurysm surveillance in Marfan syndrome?"],"prefix":"10.1016","volume":"209","author":[{"given":"Anna A.","family":"Ahimastos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Savarirayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony M.","family":"Dart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bronwyn A.","family":"Kingwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2009.08.003_bib1","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(05)67789-6","article-title":"Marfan's syndrome","volume":"366","author":"Judge","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2009.08.003_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ajmg.c.30068","article-title":"Recent progress towards a molecular understanding of Marfan syndrome","volume":"139C","author":"Dietz","year":"2005","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.atherosclerosis.2009.08.003_bib3","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1161\/CIRCULATIONAHA.107.693523","article-title":"Medical management of Marfan syndrome","volume":"117","author":"Keane","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.08.003_bib4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0002-9149(94)90405-7","article-title":"Relation between age, arterial distensibility, and aortic dilatation in the Marfan syndrome","volume":"74","author":"Jeremy","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2009.08.003_bib5","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1001\/jama.298.13.1539","article-title":"Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial","volume":"298","author":"Ahimastos","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2009.08.003_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3317\/jraas.2001.006","article-title":"The influence of angiotensin-converting enzyme inhibitors on the aorta elastin metabolism in diet-induced hypercholesterolaemia in rabbits","volume":"2","author":"Wojakowski","year":"2001","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.atherosclerosis.2009.08.003_bib7","doi-asserted-by":"crossref","first-page":"I365","DOI":"10.1161\/CIRCULATIONAHA.105.000810","article-title":"Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with Marfan syndrome","volume":"114","author":"Ikonomidis","year":"2006","journal-title":"Circulation"},{"issue":"Suppl. 1","key":"10.1016\/j.atherosclerosis.2009.08.003_bib8","first-page":"II329","article-title":"Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm","volume":"108","author":"Nataatmadja","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.08.003_bib9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0002-9149(89)90430-X","article-title":"Two-dimensional echocardiographic aortic root dimensions in normal children and adults","volume":"64","author":"Roman","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2009.08.003_bib10","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0735-1097(87)80254-1","article-title":"Evaluation of aortic insufficiency by Doppler color flow mapping","volume":"9","author":"Perry","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2009.08.003_bib11","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0735-1097(98)90059-6","article-title":"Reconsideration of echocardiographic standards for mitral valve prolapse: lack of association between leaflet displacement isolated to the apical four chamber view and independent echocardiographic evidence of abnormality","volume":"11","author":"Levine","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2009.08.003_bib12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jtcvs.2007.08.047","article-title":"Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan?","volume":"135","author":"Matt","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.atherosclerosis.2009.08.003_bib13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/nrc1094","article-title":"Basement membranes: structure, assembly and role in tumour angiogenesis","volume":"3","author":"Kalluri","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.atherosclerosis.2009.08.003_bib14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1083\/jcb.200608167","article-title":"Fibrillin-1 regulates the bioavailability of TGF-B","volume":"176","author":"Chaudhry","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1016\/j.atherosclerosis.2009.08.003_bib15","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1074\/jbc.M209256200","article-title":"Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein","volume":"278","author":"Isogai","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2009.08.003_bib16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrm2262","article-title":"Extracellular control of TGFbeta signalling in vascular development and disease","volume":"8","author":"ten Dijke","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.atherosclerosis.2009.08.003_bib17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng1116","article-title":"Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome","volume":"33","author":"Neptune","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.atherosclerosis.2009.08.003_bib18","first-page":"257","article-title":"Matrix metalloproteinases. Their role in degenerative chronic diseases of abdominal aorta","volume":"40","author":"Palombo","year":"1999","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.atherosclerosis.2009.08.003_bib19","first-page":"II331","article-title":"Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome","volume":"98","author":"Segura","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.08.003_bib20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jvs.2007.09.016","article-title":"Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome","volume":"47","author":"Xiong","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.atherosclerosis.2009.08.003_bib21","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ejvs.2008.11.027","article-title":"Expansion of small-diameter abdominal aortic aneurysms is not reflected by the release of inflammatory mediators IL-6, MMP-9 and CRP in plasma","volume":"37","author":"Karlsson","year":"2009","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.atherosclerosis.2009.08.003_bib22","doi-asserted-by":"crossref","first-page":"I282","DOI":"10.1161\/hc37t1.094856","article-title":"Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis in cystic medial degeneration associated with Marfan's syndrome","volume":"104","author":"Nagashima","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.08.003_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2009.08.003_bib24","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0741-5214(02)00139-8","article-title":"An angiotensin-converting enzyme inhibitor, not an angiotensin II type-1 receptor blocker, prevents beta-aminopropionitrile monofumarate-induced aortic dissection in rats","volume":"36","author":"Nagashima","year":"2002","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.atherosclerosis.2009.08.003_bib25","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1056\/NEJMoa055695","article-title":"Aneurysm syndromes caused by mutations in the TGF-beta receptor","volume":"355","author":"Loeys","year":"2006","journal-title":"N Engl J Med"}],"updated-by":[{"DOI":"10.1016\/j.atherosclerosis.2009.08.003","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"record-id":"1017"},{"DOI":"10.1016\/j.atherosclerosis.2016.01.027","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000}}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915009006285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915009006285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T12:16:19Z","timestamp":1556712979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915009006285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0021915009006285"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.08.003","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}